PTPRC and neoplasm: Interactions between CD8+ T cells and B CD45–endothelial cells, epithelial cells, fibroblasts, and pericytes or myeloid antigen-presenting cells, especially tumor-associated macrophages, were found to be the dominant contributors to PD-L1 and other immune checkpoint ligands.